Dawn Marie Kunz
About Dawn Marie Kunz
Dawn Marie Kunz is the Associate Director of Corporate Financial Analysis - Long Term Financial Planning at Bristol-Myers Squibb, with over 15 years of experience in financial planning and analytical support.
Title
Dawn Marie Kunz serves as the Associate Director of Corporate Financial Analysis - Long Term Financial Planning at Bristol-Myers Squibb.
Company
Bristol-Myers Squibb, a global biopharmaceutical company, currently employs Dawn Marie Kunz as their Associate Director in the Corporate Financial Analysis - Long Term Financial Planning division.
Previous Roles at Bristol-Myers Squibb
Dawn Marie Kunz has held multiple positions at Bristol-Myers Squibb over the years, starting as a Principal Financial Analyst in the US Pharmaceuticals – Pravachol division from 1999 to 2001. She then moved on to become the Finance Manager for the US Pharmaceuticals Diabetes Franchise from 2001 to 2004, after which she served as the Finance Manager for US Pharmaceuticals – Sales Operations & Planning from 2004 to 2006. Kunz was later promoted to Associate Director of Corporate Financial Analysis for Worldwide Pharmaceuticals, a role she held from 2006 to 2010.
Early Career and Experience
Before joining Bristol-Myers Squibb, Dawn Marie Kunz worked at CertainTeed Corporation as a Financial Analyst from 1993 to 1999. She has accumulated over 15 years of experience in financial planning and analysis, impacting operations through cost control, productivity enhancements, and streamlining efforts.
Education and Qualifications
Dawn Marie Kunz earned her Bachelor's Degree in Accounting and Finance with Magna Cum Laude honors from Holy Family University. Her educational background has equipped her with the skills to manage multiple cross-functional projects and deliver on objectives effectively.